Bank Of Hawaii Catalent, Inc. Transaction History

Bank Of Hawaii

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$87.2 - $114.05 $405,131 - $529,876	-4,646 Reduced 33.36%	9,281 $996,000
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $145,146 - $191,839	1,541 Added 12.44%	13,927 $1.55 Million
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $556,000 - $646,675	4,650 Added 60.11%	12,386 $1.59 Million
Q3 2021 Nov 08, 2021	BUY	$109.17 - $142.35 $844,539 - $1.1 Million	7,736 New	7,736 $1.03 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

Stay updated on Bank Of Hawaii with notifications on news.